Driving And Sustaining Innovation In Biopharma Today
Source: Life Science Leader
By Will Lewis
Working in serious and rare diseases, I have seen the nature of innovation evolve immensely over the last several decades, starting with the passage of the 1983 Orphan Drug Act. Since then, incredible advancements have enabled us to treat diseases that previously had no options for patients. This pivotal shift opened the door to other technological innovations we now know are within reach, reinvigorating the field to turn its energy toward discovering solutions for challenges previously thought unsolvable and ushering in a new wave of patient-focused medicine.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader